Guilin Jeray Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Guilin Jeray Technology Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include EJERAY. The owner is based in City, Guangxi, China.

Yifeng South Road, Qixing Dist., Guilin

4F Huatong Medical Building, No. 5

City, Guangxi, China 541004 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EJERAY
EJERAY
Registered 2021
EJERAY
EJERAY
Registered 2020

Trademark Classifications

Guilin Jeray Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Guilin Jeray Technology Co., Ltd have?

Guilin Jeray Technology Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Guilin Jeray Technology Co., Ltd file in?

Guilin Jeray Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Guilin Jeray Technology Co., Ltd's most well-known trademarks?

Guilin Jeray Technology Co., Ltd's registered trademark portfolio includes well-known marks such as EJERAY. These are among 2 currently registered trademarks in the portfolio.

What is Guilin Jeray Technology Co., Ltd's trademark registration success rate?

Guilin Jeray Technology Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.